EXTON, Pa., April 4 /PRNewswire-FirstCall/ -- Kensey Nash Corporation is scheduled to present at the Sidoti Ninth Annual New York Emerging Growth Institutional Investor Forum at the Grand Hyatt Hotel in New York, NY on Wednesday, April 6, 2005.
Joseph W. Kaufmann, Kensey Nash’s President & CEO, will deliver the Company’s presentation, beginning at approximately 2:05 p.m. (EST). The presentation materials will be available on the Company’s website (http://www.kenseynash.com/) beginning at 2:05 p.m. (EST) on Wednesday, April 6, 2005.
About Kensey Nash Corporation. Kensey Nash Corporation is a leading developer and manufacturer of absorbable biomaterials-based products with applications in the cardiology, orthopaedics, spine, drug and biologics delivery, periodontal/dental, surgical and wound care markets. The Company was a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc. The TriActiv(R) System, a novel embolic protection system, is approved for sale in the U.S. and the TriActiv(R) FX(TM) System, the second generation of the TriActiv(R) System, is approved for sale in the European Union.
Statements made during the presentation that are not historical facts are forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that a number of important factors could cause the Company’s actual results to differ materially from those in the forward-looking statements. For a more detailed discussion of these and other factors, please see the Company’s SEC filings. Results of operations in any past period should not be considered indicative of the results to be expected for future periods. Fluctuations in operating results may also result in fluctuations in the price of the Common stock.
Kensey Nash Corporation
CONTACT: Joseph W. Kaufmann, President and Chief Executive Officer ofKensey Nash, +1-610-524-0188
Web site: http://www.kenseynash.com/